RxDoctor Payments Data

Shahab Motamedi

Optometrist · Waldorf, MDNPI 1083095863

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 35.8% of the total. Reporting peaked in 2021 at $305 and has fallen 86.6% since, to $41 in 2025. That places this record below the midpoint for optometrist clinicians in MD, where the typical reported total is $712.

$816in general payments, 2019–2025

Across 20 payments — averaging $40.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$292
  • Bausch & Lomb Americas Inc.$177
  • Alcon$176
  • Heru, Inc.$58
  • Johnson & Johnson Vision Care, Inc.$44
  • Coopervision Inc.$35
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$79898%
  • Gifts$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$816 in reported general payments places this provider in the 50th percentile of 790 optometrist providers in Maryland.

See all optometrist providers in Maryland →

Medicare billing

Part B allowed, 2024
$50,095
Medicare patients
223
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost24$186
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$148

Paid to pharmacies, not to this prescriber.

Other optometrist in Waldorf

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →